HebeCell
Natick
About HebeCell
HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases the company's mission is to contribute to the fields of regenerative medicine and immuno-oncology by developing cell-based therapeutics. It produces cancer-specific natural killer (NK) cells that are developing while suspended in a liquid solution within a bioreactor, allowing them to reproduce indefinitely.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $63.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Aug 2021)
- Website: hebecellcorp.com
- Phone: +1 508 545 2190
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/hebecell-84557 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.